Cite
HARVARD Citation
Traves, P. et al. (2021). JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib. Annals of the rheumatic diseases. 80 (7), pp. 865-875. [Online].